Cosmo N.V. (VIE:COPN)

Market Cap	1.02B -8.4%
Revenue (ttm)	102.69M -43.7%
Net Income	-6.35M
EPS	-0.38
Shares Out	n/a
PE Ratio	n/a
Forward PE	899.85
Dividend	2.10 (3.57%)
Ex-Dividend Date	Apr 24, 2026

Volume	n/a
Open	59.40
Previous Close	60.60
Day's Range	58.90 - 59.40
52-Week Range	58.60 - 141.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 23, 2026

About Cosmo

Cosmo N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral ...

• Industry: Pharmaceutical Preparations
• Founded: 1997
• Employees: 365
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: COPN

Financial Performance

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 3, 2026

Data Sources Report a data error